Hokkaido University Hospital

This phase 2 trial tests a combination of two drugs—docetaxel (a chemotherapy) and pembrolizumab (an immunotherapy)—in 27 people with head and neck cancer that has returned or spread. The goal is to see if the combo shrinks tumors and helps people live longer. Participants have n…